Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 14022
Country/Region: Kenya
Year: 2016
Main Partner: Amref Health Africa
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $3,170,219 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $334,858
Care: Orphans and Vulnerable Children (HKID) $629,500
Care: TB/HIV (HVTB) $110,290
Care: Pediatric Care and Support (PDCS) $59,348
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $331,435
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $361,135
Sexual Prevention: Other Sexual Prevention (HVOP) $140,720
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $371,102
Treatment: Adult Treatment (HTXS) $708,253
Treatment: Pediatric Treatment (PDTX) $123,578
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 14
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 3
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 14
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 3
GEND_GBV Number of people receiving post-GBV care 2017 14
GEND_GBV Number of people receiving post-GBV care 2017 3
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 2,013
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 4,375
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 2,309
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 8,331
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 114,868
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 56,328
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 23,327
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 26,391
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 142,517
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 95,425
HTS_TST Service Delivery Point (Facility): Inpatient 2017 3,612
HTS_TST Service Delivery Point (Facility): Inpatient 2017 1,666
HTS_TST Service Delivery Point (Facility): Other PITC 2017 4
HTS_TST Service Delivery Point (Facility): Outpatient 2017 16,477
HTS_TST Service Delivery Point (Facility): Outpatient 2017 44,622
HTS_TST Service Delivery Point (Facility): PMTCT 2017 91,672
HTS_TST Service Delivery Point (Facility): PMTCT 2017 29,092
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 1,030
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 1,187
HTS_TST Service Delivery Point (Facility): VCT 2017 29,722
HTS_TST Service Delivery Point (Facility): VCT 2017 12,400
HTS_TST Service Delivery Point (Facility): VMMC 2017 6,458
HTS_TST Sum of Aggregated Age/Sex <15 2017 4,322
HTS_TST Sum of Aggregated Age/Sex <15 2017 12,706
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 138,195
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 82,719
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 142,517
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 95,425
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 59
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 70
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 87
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 65
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 836
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 660
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,255
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 670
KP_PREV By key population type: People in prisons and enclosed settings (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 3,518
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 3,518
OVC_SERV Age/Sex: 18+ Female 2017 668
OVC_SERV Age/Sex: 18+ Male 2017 719
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 8,882
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 9,459
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 19,728
OVC_SERV Sum of Age/Sex disaggregates 2017 1,387
PMTCT_ART Already on ART at beginning of current pregnancy 2017 143
PMTCT_ART Already on ART at beginning of current pregnancy 2017 180
PMTCT_ART New on ART 2017 317
PMTCT_ART New on ART 2017 326
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 77,849
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 17,526
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 113
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 156
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 278
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 435
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 25
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 161
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 3
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 6
PMTCT_EID Sum of Infant Age disaggregates 2017 391
PMTCT_EID Sum of Infant Age disaggregates 2017 591
PMTCT_STAT By: Known positives at entry 2017 192
PMTCT_STAT By: Known positives at entry 2017 176
PMTCT_STAT By: Number of new positives identified 2017 992
PMTCT_STAT By: Number of new positives identified 2017 288
PMTCT_STAT Number of new ANC and L&D clients 2017 81,946
PMTCT_STAT Number of new ANC and L&D clients 2017 18,449
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 77,849
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 17,526
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,184
PMTCT_STAT Sum of Positives Status disaggregates 2017 464
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 5
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 114
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 46
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 4
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 62
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 21
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 195
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 69
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 185
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 66
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 50
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 170
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 170
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 50
TB_SCREENDX Screen Result: Screened Positive for TB 2017 50
TB_SCREENDX Screen Results: Screened Positive for TB 2017 170
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 354
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 377
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 3,808
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 3,431
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 1,712
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 1,807
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 246
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 255
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 6,259
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 5,739
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 38
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,426
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 149
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 50
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 452
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 15
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 1,967
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 165
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 2,071
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 174
TX_CURR Aggregated Age/Sex: <15 Female 2017 356
TX_CURR Aggregated Age/Sex: <15 Female 2017 258
TX_CURR Aggregated Age/Sex: <15 Male 2017 375
TX_CURR Aggregated Age/Sex: <15 Male 2017 243
TX_CURR Aggregated Age/Sex: 15+ Female 2017 3,817
TX_CURR Aggregated Age/Sex: 15+ Female 2017 3,353
TX_CURR Aggregated Age/Sex: 15+ Male 2017 1,711
TX_CURR Aggregated Age/Sex: 15+ Male 2017 1,885
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 6,259
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 5,739
TX_CURR Sum of Aggregated Age/Sex <15 2017 731
TX_CURR Sum of Aggregated Age/Sex <15 2017 501
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 5,528
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 5,238
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 6,259
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 5,739
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 39
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 18
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 28
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 50
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 772
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 555
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 313
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 549
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,512
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,410
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,410
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 914
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 6,259
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 5,739
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 5,633
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 5,165
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 312
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 228
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 330
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 232
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 3,415
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 3,067
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 1,576
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 1,641
TX_PVLS Numerator: Indication: Routine 2017 4,612
TX_PVLS Numerator: Indication: Routine 2017 4,219
TX_PVLS Numerator: Indication: Targeted 2017 1,022
TX_PVLS Numerator: Indication: Targeted 2017 946
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 348
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 255
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 366
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 249
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 3,837
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 3,430
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 1,707
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 1,805
TX_PVLS_den Denominator: Indication: Routine 2017 5,124
TX_PVLS_den Denominator: Indication: Routine 2017 4,694
TX_PVLS_den Denominator: Indication: Targeted 2017 1,135
TX_PVLS_den Denominator: Indication: Targeted 2017 1,045
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 30
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 40
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 24
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 54
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 629
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,023
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 347
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 700
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,030
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,817
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,438
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 2,512
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 46
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 56
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 148
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 322
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 749
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,177
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 495
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 957
VMMC_CIRC By Age: 10-14 2017 1,475
VMMC_CIRC By Age: 15-19 2017 2,988
VMMC_CIRC By Age: 2 months - 9 years 2017 277
VMMC_CIRC By Age: 20-24 2017 1,363
VMMC_CIRC By Age: 25-29 2017 304
VMMC_CIRC By Age: 30-49 2017 173
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 6,580
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 6,580
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 6,303
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 5,826
Cross Cutting Budget Categories and Known Amounts Total: $50,000
Gender: Gender Based Violence (GBV) $50,000
GBV Prevention